Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
Researchers highlight the importance of next-generation technologies as strategic tools for drug discovery WILMINGTON, Mass.–(BUSINESS…
Year: 2023
Karen Flores Named Chief Financial Officer of Leia Inc.
Former GAN Limited CFO to lead the 3D•AI company’s financial strategy and steward continued growth…
Redfin Reports Demand For Vacation Homes Is Down More Than 50% From Pre-Pandemic Levels
The number of people locking in mortgages for second homes dropped to its lowest level…
Evolv Technology to Host Analyst Day on May 25, 2023
WALTHAM, Mass.–(BUSINESS WIRE)–Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons detection security screening, today…
Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data
In IND-enabling studies, HSB-1216 remained tightly bound within the Quatramer™ until reaching its tumor target,…
Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data
In IND-enabling studies, HSB-1216 remained tightly bound within the Quatramer™ until reaching its tumor target,…
Cerevance to Present at the Needham Healthcare Conference
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Cerevance to Present at the Needham Healthcare Conference
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Immunology of Diabetes Society Meeting
MINNEAPOLIS, April 10, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Immunology of Diabetes Society Meeting
MINNEAPOLIS, April 10, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)
FREMONT, CA, April 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)
FREMONT, CA, April 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or…
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or…
MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
CARMEL, Ind., April 10, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
CARMEL, Ind., April 10, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…